Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Maurizio Zangari

Concepts (496)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
152
2026
3082
9.880
Why?
Thalidomide
33
2016
378
2.810
Why?
Boronic Acids
17
2013
180
2.650
Why?
Pyrazines
17
2013
188
2.640
Why?
Bone Marrow
17
2022
359
1.780
Why?
Hematopoietic Stem Cell Transplantation
21
2024
610
1.750
Why?
Venous Thrombosis
8
2009
91
1.590
Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
1043
1.570
Why?
Paraproteinemias
7
2022
72
1.500
Why?
Angiogenesis Inhibitors
12
2009
186
1.440
Why?
Humans
166
2026
53230
1.320
Why?
Antibodies, Bispecific
7
2025
108
1.300
Why?
Protease Inhibitors
7
2011
59
1.250
Why?
Chromosomes, Human, Pair 1
7
2023
95
1.220
Why?
Prognosis
42
2025
2118
1.180
Why?
Proteasome Inhibitors
6
2016
104
1.170
Why?
Aged
68
2026
10429
1.160
Why?
Middle Aged
71
2026
13419
1.160
Why?
Neoplasm, Residual
7
2025
171
1.100
Why?
Antineoplastic Agents
20
2024
1232
1.090
Why?
Alkaline Phosphatase
7
2020
92
1.080
Why?
Thrombosis
6
2013
250
0.990
Why?
Transplantation, Autologous
29
2024
488
0.990
Why?
Bone Diseases
2
2021
94
0.970
Why?
Bone Remodeling
3
2016
154
0.960
Why?
Monoclonal Gammopathy of Undetermined Significance
9
2025
123
0.920
Why?
Male
78
2026
27435
0.920
Why?
Female
77
2026
28782
0.900
Why?
Osteogenesis
4
2018
374
0.870
Why?
Gene Expression Profiling
22
2025
1112
0.850
Why?
Immunologic Factors
5
2016
117
0.840
Why?
Peripheral Blood Stem Cell Transplantation
6
2012
59
0.770
Why?
Anticoagulants
6
2009
280
0.760
Why?
Neoplasms, Plasma Cell
4
2024
35
0.760
Why?
Melphalan
12
2016
180
0.760
Why?
Adult
46
2026
14534
0.730
Why?
Activated Protein C Resistance
4
2011
10
0.730
Why?
Parathyroid Hormone
4
2018
149
0.700
Why?
Antibodies, Monoclonal
4
2022
477
0.690
Why?
Aged, 80 and over
24
2026
3494
0.680
Why?
Venous Thromboembolism
3
2011
78
0.680
Why?
Plasma Cells
10
2025
234
0.650
Why?
Durapatite
1
2020
23
0.650
Why?
B-Cell Maturation Antigen
7
2025
101
0.640
Why?
Retrospective Studies
27
2026
6819
0.630
Why?
Disease-Free Survival
21
2019
466
0.630
Why?
Thromboembolism
3
2009
48
0.620
Why?
Gene Amplification
1
2019
58
0.620
Why?
Survival Rate
21
2020
949
0.610
Why?
Neoplasm Proteins
7
2020
330
0.610
Why?
Dexamethasone
14
2024
429
0.610
Why?
Myeloablative Agonists
4
2012
32
0.600
Why?
Disease Progression
17
2025
880
0.570
Why?
Gene Expression Regulation, Neoplastic
12
2021
868
0.570
Why?
Factor V
4
2011
10
0.560
Why?
Oligopeptides
3
2018
94
0.560
Why?
Bone and Bones
4
2021
501
0.560
Why?
Spinal Fractures
1
2018
37
0.560
Why?
Thymus Gland
1
2018
39
0.550
Why?
Parathyroidectomy
1
2018
46
0.540
Why?
Thyroidectomy
1
2018
61
0.540
Why?
Translocation, Genetic
8
2021
266
0.530
Why?
Risk Factors
24
2026
4017
0.530
Why?
Clinical Trials as Topic
9
2022
466
0.530
Why?
Chromosome Aberrations
11
2023
297
0.520
Why?
Survival Analysis
14
2024
659
0.520
Why?
Treatment Outcome
31
2022
5595
0.520
Why?
Calcification, Physiologic
1
2017
42
0.510
Why?
Follow-Up Studies
22
2024
2318
0.510
Why?
Pelvis
1
2017
66
0.510
Why?
Stem Cell Transplantation
11
2023
191
0.500
Why?
Osteoblasts
6
2020
480
0.490
Why?
Thrombophilia
4
2009
18
0.480
Why?
Tumor Microenvironment
5
2024
274
0.460
Why?
Chromosome Deletion
6
2023
138
0.450
Why?
Drug Resistance, Neoplasm
7
2015
350
0.440
Why?
Animals
19
2024
13526
0.430
Why?
Neoplasms
3
2009
1334
0.430
Why?
Transplantation Conditioning
7
2019
96
0.430
Why?
Neoplasm Recurrence, Local
7
2024
647
0.410
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
27
0.410
Why?
Polycythemia Vera
1
2013
6
0.400
Why?
Positron-Emission Tomography
4
2025
298
0.390
Why?
Hemostasis
3
2008
55
0.390
Why?
Neovascularization, Pathologic
4
2009
158
0.390
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
0.380
Why?
Mutation
6
2022
1337
0.370
Why?
Combined Modality Therapy
17
2024
640
0.370
Why?
Neutropenia
2
2023
113
0.370
Why?
Hematopoietic Stem Cells
2
2012
189
0.340
Why?
Bone Neoplasms
2
2010
188
0.340
Why?
Evolution, Molecular
2
2021
97
0.330
Why?
Amyloidosis
3
2009
83
0.330
Why?
Cytomegalovirus Infections
2
2026
49
0.320
Why?
Doxorubicin
7
2009
247
0.320
Why?
Immunotherapy, Adoptive
4
2024
163
0.310
Why?
Mice
11
2024
5982
0.300
Why?
Anti-Anxiety Agents
1
2009
34
0.300
Why?
In Situ Hybridization, Fluorescence
7
2023
266
0.300
Why?
Kaplan-Meier Estimate
10
2019
487
0.300
Why?
Hemorrhagic Disorders
1
2009
6
0.300
Why?
Pain
2
2009
351
0.290
Why?
Cryoglobulinemia
1
2008
13
0.290
Why?
Biopsy, Needle
1
2009
181
0.290
Why?
Pulmonary Embolism
1
2009
83
0.280
Why?
Analgesics
1
2009
104
0.280
Why?
Collagen
2
2020
215
0.280
Why?
Recurrence
11
2024
694
0.280
Why?
Risk Assessment
7
2023
1368
0.270
Why?
Hematologic Neoplasms
2
2022
101
0.270
Why?
Cell Line, Tumor
4
2023
1470
0.260
Why?
Cytomegalovirus
2
2026
42
0.260
Why?
Farnesyltranstransferase
1
2006
4
0.260
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
38
0.260
Why?
Virus Activation
2
2026
49
0.250
Why?
Waldenstrom Macroglobulinemia
2
2022
38
0.250
Why?
Osteolysis
2
2022
74
0.250
Why?
Risk
4
2014
306
0.250
Why?
Pyrroles
2
2004
73
0.250
Why?
Neoplasms, Second Primary
2
2024
75
0.250
Why?
Cell Proliferation
8
2023
1031
0.250
Why?
Cell Differentiation
4
2022
681
0.250
Why?
Time Factors
11
2021
2991
0.240
Why?
Sirolimus
1
2006
72
0.240
Why?
Logistic Models
5
2018
947
0.240
Why?
Signal Transduction
6
2021
1748
0.240
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.230
Why?
Fluorodeoxyglucose F18
4
2021
182
0.220
Why?
Plasmacytoma
2
2020
45
0.220
Why?
Immunoglobulins, Intravenous
1
2025
64
0.220
Why?
Enoxaparin
1
2004
32
0.210
Why?
Polycomb Repressive Complex 2
2
2021
48
0.210
Why?
Remission Induction
10
2021
221
0.210
Why?
Indoles
2
2004
280
0.210
Why?
Vascular Endothelial Growth Factor A
2
2004
189
0.210
Why?
Prospective Studies
9
2019
2411
0.200
Why?
Blood Coagulation
1
2003
65
0.190
Why?
Bone Resorption
2
2022
304
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.190
Why?
Hematopoietic Stem Cell Mobilization
3
2008
63
0.180
Why?
Immunoglobulin Light Chains
2
2017
90
0.180
Why?
Drug Approval
1
2022
41
0.180
Why?
Immunoconjugates
1
2022
37
0.180
Why?
Cell Cycle
2
2021
237
0.180
Why?
Randomized Controlled Trials as Topic
3
2012
630
0.180
Why?
Hemorrhage
3
2009
226
0.180
Why?
Lymphoma, B-Cell
1
2022
60
0.180
Why?
Chromosomal Instability
2
2019
16
0.180
Why?
Epigenomics
1
2021
76
0.170
Why?
Chromosomes, Human, Pair 13
5
2008
37
0.170
Why?
Patient Participation
1
2022
72
0.170
Why?
T-Lymphocytes
4
2024
321
0.170
Why?
SOXC Transcription Factors
1
2021
13
0.170
Why?
Arkansas
5
2021
2068
0.170
Why?
Calcium Phosphates
1
2020
5
0.160
Why?
Odontoblasts
1
2020
4
0.160
Why?
HL-60 Cells
1
2020
19
0.160
Why?
U937 Cells
1
2020
14
0.160
Why?
Etoposide
5
2009
71
0.160
Why?
K562 Cells
1
2020
42
0.160
Why?
Genes, Tumor Suppressor
2
2021
73
0.160
Why?
NIH 3T3 Cells
1
2020
52
0.160
Why?
MCF-7 Cells
1
2020
65
0.160
Why?
Kidney Diseases
2
2020
230
0.160
Why?
Mammals
1
2020
58
0.160
Why?
Practice Guidelines as Topic
1
2023
502
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Protein C
2
2011
20
0.160
Why?
Leukemia, Plasma Cell
1
2020
35
0.160
Why?
Myelodysplastic Syndromes
3
2007
87
0.160
Why?
beta 2-Microglobulin
5
2008
39
0.160
Why?
Cisplatin
6
2009
282
0.160
Why?
HeLa Cells
1
2020
243
0.160
Why?
HEK293 Cells
1
2020
235
0.150
Why?
Busulfan
1
2019
18
0.150
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.150
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
Atrial Fibrillation
1
2022
197
0.150
Why?
Imaging, Three-Dimensional
2
2017
145
0.150
Why?
Epigenesis, Genetic
2
2020
412
0.150
Why?
Genome-Wide Association Study
1
2020
184
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.150
Why?
Fractures, Compression
1
2018
17
0.140
Why?
Healthcare Disparities
1
2022
312
0.140
Why?
Predictive Value of Tests
4
2009
934
0.140
Why?
Spleen
1
2019
166
0.140
Why?
Genomic Instability
2
2016
88
0.140
Why?
Fibrinolysis
2
2009
6
0.140
Why?
Phosphotransferases
1
2018
18
0.140
Why?
Cytokines
3
2007
627
0.140
Why?
Blood Coagulation Factors
2
2009
17
0.140
Why?
Bacteremia
1
2019
87
0.140
Why?
Antineoplastic Agents, Alkylating
6
2008
78
0.140
Why?
Adipocytes
1
2018
131
0.140
Why?
Cell Line
1
2020
1016
0.130
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Cluster Analysis
4
2012
237
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Metaphase
4
2016
47
0.130
Why?
Heparin, Low-Molecular-Weight
2
2007
22
0.130
Why?
Ultrasonography, Doppler
2
2007
42
0.130
Why?
Renal Insufficiency
4
2010
108
0.120
Why?
Calcium
1
2018
373
0.120
Why?
Fibrinolytic Agents
2
2007
132
0.120
Why?
Clonal Evolution
1
2016
59
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.120
Why?
Tumor Burden
3
2020
132
0.120
Why?
Gene Expression
1
2018
618
0.120
Why?
Disease Models, Animal
4
2016
1517
0.120
Why?
Bone Marrow Transplantation
4
2022
110
0.110
Why?
Multivariate Analysis
7
2021
598
0.110
Why?
Tumor Suppressor Protein p53
1
2017
228
0.110
Why?
Genes, Neoplasm
1
2015
31
0.110
Why?
Polymorphism, Single Nucleotide
2
2020
505
0.110
Why?
Immunotherapy
2
2016
266
0.110
Why?
Gene Dosage
1
2015
76
0.110
Why?
Salvage Therapy
6
2006
138
0.110
Why?
Incidence
2
2009
1085
0.110
Why?
Algorithms
1
2018
667
0.110
Why?
Transcriptome
3
2025
367
0.110
Why?
Osteoclasts
3
2022
428
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Case-Control Studies
4
2011
1212
0.100
Why?
Altitude
1
2013
17
0.100
Why?
Tomography, X-Ray Computed
2
2017
1180
0.100
Why?
Janus Kinase 2
1
2013
27
0.100
Why?
Chromosomes, Human, Pair 11
3
2020
56
0.100
Why?
Cross-Sectional Studies
3
2023
1723
0.100
Why?
STAT3 Transcription Factor
2
2010
89
0.100
Why?
Models, Biological
1
2016
737
0.100
Why?
Protein-Tyrosine Kinases
3
2018
87
0.100
Why?
Bone Density Conservation Agents
2
2010
75
0.100
Why?
Mice, Inbred C57BL
1
2018
1925
0.090
Why?
Cytogenetic Analysis
6
2014
79
0.090
Why?
Creatinine
2
2010
158
0.090
Why?
Viremia
1
2012
23
0.090
Why?
Clone Cells
2
2023
76
0.090
Why?
Models, Genetic
2
2016
169
0.090
Why?
Clinical Trials, Phase II as Topic
1
2012
48
0.090
Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.090
Why?
Viper Venoms
1
2011
6
0.090
Why?
Drug Evaluation, Preclinical
1
2012
142
0.090
Why?
Epidemiologic Methods
2
2008
47
0.090
Why?
NF-kappa B
2
2018
327
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
7
0.080
Why?
Arsenicals
1
2010
15
0.080
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
18
0.080
Why?
Oxides
1
2010
21
0.080
Why?
Mutation Rate
2
2021
36
0.080
Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.080
Why?
Hypercalcemia
1
2010
34
0.080
Why?
Transplantation, Homologous
4
2003
154
0.080
Why?
Cyclophosphamide
4
2003
178
0.080
Why?
Janus Kinase 1
1
2010
16
0.080
Why?
MAP Kinase Kinase 1
1
2010
22
0.080
Why?
Anemia
1
2010
76
0.080
Why?
Antineoplastic Agents, Hormonal
2
2007
56
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Administration, Oral
2
2009
456
0.080
Why?
Proteinuria
1
2010
38
0.080
Why?
Genomics
2
2023
271
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
84
0.080
Why?
Diphosphonates
1
2010
92
0.080
Why?
Dose-Response Relationship, Drug
3
2008
1367
0.080
Why?
Lorazepam
1
2009
13
0.080
Why?
Receptors, Retinoic Acid
1
2009
22
0.080
Why?
Hyperhomocysteinemia
1
2009
29
0.080
Why?
Oxycodone
1
2009
27
0.080
Why?
Anesthesia, Local
1
2009
18
0.080
Why?
Prednisone
1
2009
101
0.070
Why?
Histones
2
2021
318
0.070
Why?
Tretinoin
1
2009
53
0.070
Why?
Hemostatic Techniques
1
2009
32
0.070
Why?
Plasma Exchange
1
2009
25
0.070
Why?
Transcription Factors
2
2023
571
0.070
Why?
Vasculitis
1
2008
28
0.070
Why?
Vincristine
3
2003
89
0.070
Why?
Syndecan-1
3
2021
73
0.070
Why?
Biopsy
3
2018
600
0.070
Why?
Radiopharmaceuticals
2
2021
198
0.070
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Drug Therapy, Combination
1
2009
405
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Bone Development
1
2009
68
0.070
Why?
Staphylococcal Infections
2
2019
271
0.070
Why?
Carrier Proteins
1
2010
315
0.070
Why?
Pain Measurement
1
2009
259
0.070
Why?
Platelet Aggregation
1
2008
77
0.070
Why?
Thrombocytopenia
1
2009
89
0.070
Why?
Double-Blind Method
1
2009
729
0.070
Why?
Brain Diseases, Metabolic
1
2007
5
0.070
Why?
Phlebography
1
2007
55
0.070
Why?
Hyperammonemia
1
2007
23
0.070
Why?
Myeloma Proteins
1
2007
26
0.060
Why?
Antimetabolites
1
2006
12
0.060
Why?
Chi-Square Distribution
1
2007
291
0.060
Why?
Cell Communication
2
2023
73
0.060
Why?
Magnetic Resonance Imaging
4
2007
1583
0.060
Why?
Partial Thromboplastin Time
1
2006
15
0.060
Why?
Osteoprotegerin
1
2006
53
0.060
Why?
Acetaminophen
1
2009
277
0.060
Why?
Heterozygote
1
2006
89
0.060
Why?
Antibiotics, Antineoplastic
1
2006
83
0.060
Why?
Gastrointestinal Neoplasms
1
2006
44
0.060
Why?
Models, Statistical
1
2007
229
0.060
Why?
Pilot Projects
1
2008
726
0.060
Why?
Age Factors
3
2005
1136
0.060
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Apoptosis
1
2010
1139
0.060
Why?
Neovascularization, Physiologic
1
2005
86
0.060
Why?
Gene Deletion
2
2003
279
0.060
Why?
Syndrome
2
2019
248
0.060
Why?
ROC Curve
1
2025
246
0.050
Why?
Killer Cells, Natural
1
2024
113
0.050
Why?
Ferritins
1
2024
38
0.050
Why?
Glucuronidase
1
2003
47
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
80
0.050
Why?
DNA Methylation
2
2020
592
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
145
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
58
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Antibodies
1
2024
147
0.050
Why?
Immunosuppressive Agents
1
2005
253
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2006
412
0.050
Why?
Discitis
1
2003
11
0.050
Why?
Myeloproliferative Disorders
1
2003
31
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Rats
1
2009
3162
0.050
Why?
Tumor Cells, Cultured
3
2010
441
0.050
Why?
Antigens, CD34
1
2003
76
0.050
Why?
Platelet Count
3
2008
68
0.050
Why?
Patients
1
2022
52
0.050
Why?
Geography
1
2022
65
0.050
Why?
Leukemia, Myeloid
1
2002
40
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Drug Interactions
1
2002
196
0.050
Why?
Receptors, Antigen, T-Cell
1
2022
52
0.050
Why?
Chromosome Disorders
1
2002
32
0.040
Why?
United States Food and Drug Administration
1
2022
93
0.040
Why?
Enzyme Inhibitors
1
2004
371
0.040
Why?
Oncogenes
1
2021
61
0.040
Why?
Patient Selection
1
2023
273
0.040
Why?
Phylogeny
1
2022
231
0.040
Why?
Hypothyroidism
1
2002
58
0.040
Why?
Central Nervous System Neoplasms
1
2002
69
0.040
Why?
RANK Ligand
1
2022
188
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.040
Why?
Cohort Studies
2
2020
1557
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
110
0.040
Why?
Chromatin
1
2021
145
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2022
238
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Pyrimidines
1
2022
205
0.040
Why?
Aneuploidy
1
2020
17
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Endothelium, Vascular
1
2002
262
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
76
0.040
Why?
Longitudinal Studies
2
2016
774
0.040
Why?
Transcriptional Elongation Factors
1
2020
17
0.040
Why?
Protein Kinase Inhibitors
1
2022
233
0.040
Why?
Genetic Loci
1
2020
48
0.040
Why?
Postoperative Complications
1
2007
1099
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
RNA, Messenger
3
2010
1133
0.040
Why?
Genetic Variation
1
2020
223
0.040
Why?
Neoplastic Stem Cells
2
2015
90
0.040
Why?
Health Status Disparities
1
2022
221
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
180
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
29
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Proline
1
2018
31
0.040
Why?
DNA-Binding Proteins
1
2021
423
0.040
Why?
Bone Marrow Cells
2
2014
188
0.040
Why?
Recombinant Proteins
2
2010
489
0.030
Why?
Promoter Regions, Genetic
1
2020
465
0.030
Why?
Fluorescent Dyes
1
2018
90
0.030
Why?
Proteolysis
1
2018
105
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.030
Why?
Oncogene Proteins, Fusion
1
2018
62
0.030
Why?
Extracellular Matrix
1
2018
116
0.030
Why?
Kidney Function Tests
1
2017
55
0.030
Why?
Cell Movement
1
2018
279
0.030
Why?
False Positive Reactions
1
2017
66
0.030
Why?
Glomerular Filtration Rate
1
2017
128
0.030
Why?
Amino Acid Sequence
1
2018
563
0.030
Why?
Genetic Predisposition to Disease
1
2020
533
0.030
Why?
Cell Survival
2
2010
600
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Mice, SCID
2
2009
180
0.030
Why?
Chromosome Mapping
2
2006
145
0.030
Why?
Glycolysis
1
2016
76
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
98
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
148
0.030
Why?
Serum Albumin
2
2008
56
0.030
Why?
Syndecans
2
2006
37
0.030
Why?
Proteoglycans
2
2006
86
0.030
Why?
Cells, Cultured
1
2018
1569
0.030
Why?
Drug Monitoring
1
2015
81
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Myocardium
1
2017
471
0.030
Why?
Karyotype
1
2014
22
0.030
Why?
Proportional Hazards Models
2
2006
445
0.030
Why?
Membrane Glycoproteins
2
2006
238
0.030
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
Neoplasm Staging
2
2007
774
0.020
Why?
Infusions, Intravenous
2
2003
211
0.020
Why?
RNA Interference
1
2013
181
0.020
Why?
Viral Load
1
2012
83
0.020
Why?
Graft vs Host Disease
2
2003
93
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
United States
1
2022
5409
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
179
0.020
Why?
CDC2-CDC28 Kinases
1
2010
11
0.020
Why?
Femur
1
2010
133
0.020
Why?
Long-Term Care
1
2010
50
0.020
Why?
RNA, Small Interfering
1
2010
214
0.020
Why?
Peripheral Nervous System Diseases
1
2010
60
0.020
Why?
Down-Regulation
1
2010
344
0.020
Why?
Bone Diseases, Metabolic
1
2010
79
0.020
Why?
Abnormalities, Multiple
1
2010
166
0.020
Why?
Cell Transformation, Neoplastic
1
2010
187
0.020
Why?
Protein Isoforms
1
2009
124
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Ligands
1
2009
203
0.020
Why?
Rabbits
1
2009
372
0.020
Why?
Polyethylene Glycols
1
2008
95
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
579
0.020
Why?
Hemoglobins
1
2008
114
0.020
Why?
Age Distribution
1
2007
175
0.020
Why?
Diagnosis, Differential
1
2010
1038
0.020
Why?
C-Reactive Protein
1
2008
152
0.020
Why?
Mass Screening
1
2010
362
0.020
Why?
Ammonia
1
2007
89
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Bone Density
1
2009
397
0.020
Why?
Brain
2
2007
1350
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Evidence-Based Medicine
1
2007
275
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Radiography
1
2007
476
0.010
Why?
Coculture Techniques
1
2006
146
0.010
Why?
Leukemia, Myeloid, Acute
1
2007
208
0.010
Why?
Data Interpretation, Statistical
1
2006
169
0.010
Why?
Neoplasms, Experimental
1
2006
112
0.010
Why?
Interferon-alpha
1
2005
53
0.010
Why?
Survivors
1
2006
120
0.010
Why?
Mice, Transgenic
1
2006
561
0.010
Why?
Databases, Factual
1
2007
742
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Odds Ratio
1
2005
567
0.010
Why?
Trisomy
1
2003
34
0.010
Why?
History, 21st Century
1
2003
60
0.010
Why?
Endothelial Growth Factors
1
2003
11
0.010
Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
Why?
Lymphokines
1
2003
20
0.010
Why?
Fusion Proteins, bcr-abl
1
2003
20
0.010
Why?
History, 20th Century
1
2003
97
0.010
Why?
Stem Cell Factor
1
2003
7
0.010
Why?
Confidence Intervals
1
2003
158
0.010
Why?
Probability
1
2003
171
0.010
Why?
Interphase
1
2003
9
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Diploidy
1
2003
25
0.010
Why?
Leukocyte Count
1
2003
71
0.010
Why?
Back Pain
1
2003
40
0.010
Why?
Interferons
1
2002
39
0.010
Why?
Cell Count
1
2003
141
0.010
Why?
Sex Factors
1
2005
747
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2003
107
0.010
Why?
Drug Administration Schedule
1
2003
370
0.010
Why?
Thyroid Function Tests
1
2002
28
0.010
Why?
Thyrotropin
1
2002
49
0.010
Why?
Prevalence
1
2005
1034
0.010
Why?
Fatal Outcome
1
2002
193
0.010
Why?
Neutrophils
1
2003
153
0.010
Why?
Tissue Donors
1
2003
130
0.010
Why?
Cell Division
1
2002
289
0.010
Why?
Reoperation
1
2003
476
0.010
Why?
Acute Disease
1
2002
393
0.010
Why?
Up-Regulation
1
2002
456
0.010
Why?
Anti-Bacterial Agents
1
2003
830
0.010
Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description